PRMA Access Accelerator®
Gain competitive advantage with the PRMA Access Accelerator®. Virtual advisory boards, forums, and online surveys that fast forward your market
The PRMA Access Accelerator® digital application provides on-demand expert insight that informs the development of your product from early portfolio investment decisions to late-stage market access planning and testing.
Drive real-time payer insight through virtual advisory boards and online surveys
Tailored interactions with payers that are strategically supported
We will partner with you to design your bespoke PRMA Access Accelerator® project. Projects range from one-off quantitative studies to longitudinal qualitative approaches. Choose the interactions you need, to ask probing questions as the landscape is evolving. All payers are screened and contracted to PRMA Consulting and interactions are conducted double blinded.
Inform development from early-portfolio investment to late-stage market access
The PRMA Access Accelerator® can be utilized across multiple phases of your products development to assess investment risks and opportunities, test assumptions, inform strategies, validate value messaging, and support successful negotiation. It can be employed alongside traditional forms of primary research or as a standalone service depending on your requirements.
Test the viability of your product within evolving HTA and payer landscapes
Advisors are selected, in line with your compliance requirements, from our global community of experts. We partner with you to design and create your customized research. A dedicated consultancy team will actively moderate and quality control outputs on an ongoing basis, supported by your advisor liaison manager who has frequent contact with advisors.
Harness our strategic expertise to maximize your commercial opportunities
Capitalize on PRMA Consulting’s multidisciplinary team. We have in-depth disease area knowledge, and extensive experience of providing solutions-orientated market access strategies at global, regional, and affiliate levels. Your final report will include key discussion points and findings, verbatim quotes, strategic insights, and practical recommendations.
We are based in the US, so the PRMA Access Accelerator® survey gave us a quick and cost-effective way to assess the payer landscape in Europe and test our assumptions. The value this research added to our planning shouldn’t be underestimated.
Director of Business Development, top-10 biotechnology company
The PRMA Access Accelerator® virtual advisory board has transformed our approach. What used to take 6 months, we can now do in less than 6 weeks, for a fraction of the cost, without losing the personal touch…and we don’t need to travel.
Market Access Manager, top-10 pharmaceutical company
Demo the PRMA Access Accelerator® for yourself